Companies
Insulet
Medical devicesActon, MassachusettsPODDAbout 5,400 employees
More about Insulet
Medical device company that makes the Omnipod tubeless insulin pump for people with type 1 and type 2 diabetes.
Revenue
$2.7B
Fiscal 2025, up about 31%
Employees
About 5,400
As of December 2025, full-time
Stock
PODD
Nasdaq
Headquarters
Acton, Massachusetts
CEO
Ashley McEvoy
Since April 2025
BrandsOmnipod 5, Omnipod DASH
Current strategyGrowing Omnipod 5 in type 1 and type 2 diabetes and internationally, with Omnipod 6 and a fully closed-loop type 2 system in development and a target of about 20% annual revenue growth through 2028
Recent workforce changesFull-time headcount grew 38% in 2025 to about 5,400
CompetitorsTandem Diabetes Care, Medtronic Diabetes (MiniMed), Beta Bionics
Checked October 11, 2026 · Sources: sec.gov, businesswire.com, medtechdive.com
Be the first to post about Insulet
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow Insulet to see the first post in your watchlist.
Follow Insulet in a feed reader, no account needed: RSS feed